Description
RADIOPHARMACEUTICALS
First action · last action
2020-02-28 · 2026-03-17
Transactions
15
First transaction's obligation
$359,751
Base + all options value (sum of deltas)
$882,014
Extent competed
COMPETED UNDER SAP
Other than full & open authority
—
Set-aside
NO SET ASIDE USED.
Offers received
2
SDVOSB flag on record
No
NAICS
325412 · PHARMACEUTICAL PREPARATION MANUFACTURING
Modification chain · 15 transactions
Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.
- Base2020-02-28+$359,751= $359,751
- Mod P000012021-02-28+$361,307= $721,059
- Mod P000022021-03-01+$0= $721,059
- Mod P000032021-07-30+$0= $721,059
- Mod P000052022-03-01+$363,535= $1,084,594
- Mod P000042022-03-16-$1,735= $1,082,858
- Mod P000062022-12-02-$188,957= $893,901
- Mod P000072022-12-15-$156,610= $737,291
- Mod P000082023-02-28+$367,093= $1,104,384
- Mod P000092023-05-30-$344,442= $759,942
- Mod P000102024-02-29+$370,689= $1,130,631
- Mod P000112025-02-28+$264,989= $1,395,620
- Mod P000122025-03-04+$0= $1,395,620
- Mod P000132025-08-08-$358,877= $1,036,743
- Mod P000142026-03-17-$154,729= $882,014
| Transaction | Action date | This action (delta) | Running total | Description on this transaction |
|---|---|---|---|---|
| Base | 2020-02-28 | +$359,751 | $359,751 | RADIOPHARMACEUTICALS |
| Mod P00001· EXERCISE AN OPTION | 2021-02-28 | +$361,307 | $721,059 | RADIOPHARMACEUTICALS |
| Mod P00002· OTHER ADMINISTRATIVE ACTION | 2021-03-01 | +$0 | $721,059 | RADIOPHARMACEUTICALS |
| Mod P00003· OTHER ADMINISTRATIVE ACTION | 2021-07-30 | +$0 | $721,059 | RADIOPHARMACEUTICALS |
| Mod P00005· EXERCISE AN OPTION | 2022-03-01 | +$363,535 | $1,084,594 | RADIOPHARMACEUTICALS |
| Mod P00004· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE | 2022-03-16 | −$1,735 | $1,082,858 | RADIOPHARMACEUTICALS |
| Mod P00006· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE | 2022-12-02 | −$188,957 | $893,901 | RADIOPHARMACEUTICALS |
| Mod P00007· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE | 2022-12-15 | −$156,610 | $737,291 | RADIOPHARMACEUTICALS |
| Mod P00008· EXERCISE AN OPTION | 2023-02-28 | +$367,093 | $1,104,384 | RADIOPHARMACEUTICALS |
| Mod P00009· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE | 2023-05-30 | −$344,442 | $759,942 | RADIOPHARMACEUTICALS |
| Mod P00010· EXERCISE AN OPTION | 2024-02-29 | +$370,689 | $1,130,631 | RADIOPHARMACEUTICALS |
| Mod P00011· EXERCISE AN OPTION | 2025-02-28 | +$264,989 | $1,395,620 | RADIOPHARMACEUTICALS |
| Mod P00012· NOVATION AGREEMENT | 2025-03-04 | +$0 | $1,395,620 | RADIOPHARMACEUTICALS |
| Mod P00013· FUNDING ONLY ACTION | 2025-08-08 | −$358,877 | $1,036,743 | RADIOPHARMACEUTICALS |
| Mod P00014· OTHER ADMINISTRATIVE ACTION | 2026-03-17 | −$154,729 | $882,014 | RADIOPHARMACEUTICALS |
Related awards · 11
Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.
Other VA awards to the same recipient (UEI UA3GDUKRYSM5)
| Award | Office · PSC / listing | Net obligations | FY |
|---|---|---|---|
| 36C25626P0728 | 256-NETWORK CONTRACT OFFICE 16 (36C256) · 6515 · MEDICAL AND SURGICAL INSTRUMENTS, EQUIPMENT, AND SUPPLIES | $839,629 | FY2026 |
| 36C24526N0404 | 245-NETWORK CONTRACT OFFICE 5 (36C245) · 6505 · DRUGS AND BIOLOGICALS | $510,182 | FY2026 |
| 36C26126N0371 | 261-NETWORK CONTRACT OFFICE 21 (36C261) · 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS | $250,075 | FY2026 |
| 36C26226N0409 | 262-NETWORK CONTRACT OFFICE 22 (36C262) · 6505 · DRUGS AND BIOLOGICALS | $1,561,204 | FY2026 |
| 36C26226N0410 | 262-NETWORK CONTRACT OFFICE 22 (36C262) · 6505 · DRUGS AND BIOLOGICALS | $752,000 | FY2026 |
| 36C25226P0239 | 252-NETWORK CONTRACT OFFICE 12 (36C252) · 6505 · DRUGS AND BIOLOGICALS | $303,486 | FY2026 |
Other recipients under 6505 from 260-NETWORK CONTRACT OFFICE 20 (36C260) (most recent first)
| Award | Recipient | Office | Net obligations | FY |
|---|---|---|---|---|
| 36C26026F0379 | COSETTE PHARMACEUTICALS, INC. | 260-NETWORK CONTRACT OFFICE 20 (36C260) | $3,466 | FY2026 |
| 36C26026P0671 | MCKESSON PLASMA AND BIOLOGICS LLC | 260-NETWORK CONTRACT OFFICE 20 (36C260) | $18,262 | FY2026 |
| 36C26026F0349 | AGIOS PHARMACEUTICALS, INC. | 260-NETWORK CONTRACT OFFICE 20 (36C260) | $73,080 | FY2026 |
| 36C26026F0306 | BRACCO DIAGNOSTICS INC. | 260-NETWORK CONTRACT OFFICE 20 (36C260) | $337,422 | FY2026 |
| 36C26026F0298 | PROGENICS PHARMACEUTICALS INC | 260-NETWORK CONTRACT OFFICE 20 (36C260) | $469,134 | FY2026 |
Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_36C26020P0344_3600_-NONE-_-NONE- · retrieved 2026-09-26.